August 25, 2021
Effective for dates of service on or after August 12, 2021, the U.S. Food and Drug
Administration (FDA) amended the Emergency Use Authorizations (EUA) for the
Pfizer-BioNTech and Moderna COVID-19 vaccines to permit the administration of a third
dose. The Department of Health Care Services (DHCS) is aggressively pursuing the
necessary system and operational changes required to enable successful claims
adjudication for administration of a third dose of the Pfizer-BioNTech and Moderna
Medi-Cal will announce when the claims adjudication system is prepared to appropriately
adjudicate submitted claims, as well as any additional instruction providers should
utilize when billing.
For the most current information regarding Medi-Cal’s COVID-19 Response, see the COVID-19
Medi-Cal Response page on the Medi-Cal Provider website.